MedTrace Logo

The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan

NCT05522881 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2026-01-20

No results posted yet for this study

Summary

We will use the next-generation sequencing (NGS) technology to identify genomic alterations of Taiwanese HPV positive and negative oropharyngeal squamous cell carcinoma (OPSCC) for novel biomarker development and the study design of potential clinical trials or translational research.

Conditions

  • Oropharyngeal Squamous Cell Carcinoma

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER

  • Taipei Veterans General Hospital, Taiwan

    collaborator OTHER_GOV

  • China Medical University Hospital

    collaborator OTHER

  • Taichung Veterans General Hospital

    collaborator OTHER

  • National Cheng-Kung University Hospital

    collaborator OTHER

  • Kaohsiung Veterans General Hospital.

    collaborator OTHER

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    collaborator OTHER

  • National Health Research Institutes, Taiwan

    lead OTHER

Principal Investigators

  • Pei-Jen Lou, MD, PhD · National Taiwan University Hospital

  • Shang-Hung Chen, MD, PhD · National Health Research Institutes, Taiwan

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-25
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05522881 on ClinicalTrials.gov